Loomis Sayles & CO L P Amgen Inc Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

A detailed history of Loomis Sayles & CO L P transactions in Amgen Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 854 shares of AMGN stock, worth $245,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

854

Previous 801 6.62%

Holding current value

$245,840

Previous $250,000 10.0%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $16,397 - $17,881	53 Added 6.62%	854 $275,000
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $788 - $957	-3 Reduced 0.37%	801 $250,000
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $39,523 - $47,710	-147 Reduced 15.46%	804 $229,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $21,223 - $23,942	-83 Reduced 8.03%	951 $274,000
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $24,707 - $30,674	-113 Reduced 9.85%	1,034 $278,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $43,711 - $51,687	-204 Reduced 15.1%	1,147 $255,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $99,121 - $120,812	439 Added 48.14%	1,351 $327,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $183,911 - $233,681	-803 Reduced 46.82%	912 $240,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $369,685 - $416,938	1,647 Added 2422.06%	1,715 $387,000
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 22.73%	68 $17,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $2,850 - $3,153	-13 Reduced 12.87%	88 $21,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $10,540 - $12,062	-53 Reduced 34.42%	101 $23,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $424 - $497	-2 Reduced 1.28%	154 $33,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $1,167 - $1,295	5 Added 3.31%	156 $38,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.21 Million - $1.41 Million	-5,467 Reduced 97.31%	151 $38,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $337,552 - $401,965	1,560 Added 38.44%	5,618 $1.29 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $559,170 - $621,843	-2,383 Reduced 37.0%	4,058 $1.03 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $651 Million - $799 Million	-3,290,789 Reduced 99.8%	6,441 $1.52 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $33.3 Million - $44.2 Million	-182,745 Reduced 5.25%	3,297,230 $668 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $21.7 Million - $27.9 Million	114,809 Added 3.41%	3,479,975 $839 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $5.8 Million - $6.95 Million	33,302 Added 1.0%	3,365,166 $651 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $185,537 - $217,491	1,113 Added 0.03%	3,331,864 $614 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $2.71 Million - $3.06 Million	14,985 Added 0.45%	3,330,751 $633 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $24.3 Million - $28.4 Million	-136,440 Reduced 3.95%	3,315,766 $645 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $11.3 Million - $12.7 Million	60,875 Added 1.8%	3,452,206 $716 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $11.6 Million - $13 Million	69,722 Added 2.1%	3,391,331 $626 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $874,089 - $1.02 Million	5,159 Added 0.16%	3,321,609 $566 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $8.62 Million - $9.63 Million	51,080 Added 1.56%	3,316,450 $577 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $13 Million - $14.8 Million	77,724 Added 2.44%	3,265,370 $609 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,187,646	3,187,646 $549 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Amgen Inc Transaction History